The Laboratory tubes

Product

Factory making 3-O-Ethyl Ascorbic Acid 86404-04-8 - Spironolactone 52-01-7 Urinary system – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We take "customer-friendly, quality-oriented, integrative, innovative" as objectives. "Truth and honesty" is our management ideal for Cidofovir hydrate 149394-66-1, Moxidectin 113507-06-5, S-Acetyl-L-Glutathione 3054-47-5, Trust us and you will gain more. Please feel free to contact us for more information, we assure you of our best attention at all times.
Factory making 3-O-Ethyl Ascorbic Acid 86404-04-8 - Spironolactone 52-01-7 Urinary system – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 50kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information:  Not dangerous goods

Spironolactone

Introduction

Spironolactone, is a medication that is primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It is also used in the treatment of high blood pressure, low blood potassium that does not improve with supplementation, early puberty in boys, acne and excessive hair growth in women, and as a part of transgender hormone therapy in transfeminine people.

Specification (USP42)

Item

Specification

Appearance

Light cream-colored to light tan crystalline powder.

Solubility (annual)

Freely soluble in benzene and in chloroform; soluble in ethyl acetate and in alcohol; slightly soluble in methanol and in fiexed oils; practically insoluble in water.

Identification

Infrared Absorption: meets the requirement

HPLC: meets the requirement

Limit of mercapto compounds

≤0.10mL of 0.010N iodine is consumed

Organic impurities

Related compound B ≤0.2%

Related compound A ≤0.2%

Related compound C ≤0.2%

Related compound D ≤0.3%

Epimer ≤0.3%

Related compound I ≤0.1%

Any unspecified impurity ≤0.10%

Total impurities ≤1.0%

Optical rotation -41°~ -45°
Loss on drying ≤0.5%
Residual solvents (In-house) Methanol ≤3000ppm
Tetrahydrofuran ≤720ppm
DMF ≤880ppm
Particle size (In-house) 95% not more than 20 microns

Assay

97.0% ~103.0% on the dried basis


Product detail pictures:

Factory making 3-O-Ethyl Ascorbic Acid 86404-04-8 - Spironolactone 52-01-7 Urinary system – Neore detail pictures


Related Product Guide:

Our target is to consolidate and improve the quality and service of existing products, meanwhile constantly develop new products to meet different customers' demands for Factory making 3-O-Ethyl Ascorbic Acid 86404-04-8 - Spironolactone 52-01-7 Urinary system – Neore , The product will supply to all over the world, such as: Guatemala, Morocco, Congo, Establish long term and win-win business relationships with all our customers, share the success and enjoy the happiness of spreading our products to the world together. Trust us and you will gain more. Please feel free to contact us for more information, we assure you of our best attention at all times.
  • This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
    5 Stars By Doris from Bogota - 2018.07.26 16:51
    Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
    5 Stars By Julie from Egypt - 2018.12.10 19:03